SCHEMBL7418635

SCHEMBL7418635

CCn1ncc2c(NCc3ccncc3)c3ccccc3nc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.51
KMT2A Q03164 2/20 0.51
RAD52 P43351 1/20 0.51
PDE5A O76074 3/20 0.46
PTGS1 P23219 1/20 0.42
TBXAS1 P24557 1/20 0.42
PTGS2 P35354 1/20 0.42
ALDH1A1 P00352 2/20 0.41
MAPT P10636 1/20 0.41
PDE4B Q07343 2/20 0.41
RET P07949 1/20 0.40
ADRA2C P18825 1/20 0.40
PDE9A O76083 1/20 0.40
CDK2 P24941 2/20 0.39
ABL1 P00519 1/20 0.39
SRC P12931 1/20 0.39
MAPKAPK2 P49137 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7028354 0.93 KMT2A (0.60) POLBKMT2ARAD52ALDH1A1MAPT
SCHEMBL8444030 0.89 ALDH1A1 (0.50) POLBKMT2ARAD52PDE5APTGS1
SCHEMBL7420540 0.87 POLB (0.50) POLBKMT2ARAD52PDE5APDE4B
SCHEMBL7420650 0.86 PDE5A (0.50) POLBKMT2ARAD52PDE5AALDH1A1
SCHEMBL7416586 0.85 EGFR (0.52) POLBKMT2ARAD52PDE5AALDH1A1
Hydrochloric Acid SCHEMBL7423114 0.84 EGFR (0.51) POLBKMT2ARAD52PDE5AALDH1A1
SCHEMBL7423097 0.83 POLB (0.48) POLBKMT2ARAD52PDE5APDE4B
SCHEMBL7418050 0.83 BCHE (0.50) POLBKMT2APDE5AALDH1A1MAPT
SCHEMBL7422618 0.82 POLB (0.46) POLBKMT2ARAD52PDE5AALDH1A1
SCHEMBL7419604 0.82 ACHE (0.53) POLBKMT2ARAD52PDE5AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6008226-A AN ENZYME INHIBITOR OF C-GMP-PHOSPHODIESTERASE FOR TREATING HEART FAILURE, HYPERTENSION, REVERSING OR REDUCING NITRATE-INDUCED TOLERANCE AND ANGINA PECTORIS, CONGESTIVE HEART DISEASE AND MYOCARDIAL INFARCTION SANOFI-SYNTHELABO (FR) 1999-12-28 US disclosed
US-5852035-A Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines CELL PATHWAYS, INC. (US) 1998-12-22 US disclosed
US-5843956-A Substituted N-arylmethyl and heterocyclylmethyl-1H-pyrazolo (3,4-b) quinolin-4-amines and compositions and methods of use thereof SANOFI (FR) 1998-12-01 US disclosed
US-5614530-A GMP PHOSPHODIESTERASE INHIBITOR, HYPOTENSIVE STERLING WINTHROP INC. (US) 1997-03-25 US disclosed
WO-1996028159-A1 SUBSTITUTED N-ARYLMETHYL AND HETEROCYCLYLMETHYL-1H-PYRAZOLO[3,4-b]QUINOLIN-4-AMINES AND COMPOSITIONS AND METHODS OF USE THEREOF SANOFI WINTHROP, INC. (US) 1996-09-19 WO disclosed